Showing 1 - 15 results of 15 for search 'Miguel Ángel Calleja Hernandez', query time: 0.06s
Refine Results
-
1
Hospital Pharmacy and Critical Care Medicine: a necessary alliance by María Cruz Martin-Delgado, Miguel Ángel Calleja-Hérnandez
Published 2018-09-01
Article -
2
MAPEX: look deeper, looking away by Ramón Morillo Verdugo, Javier Sáez de la Fuente, Miguel Ángel Calleja Hernandez
Published 2015-07-01
Article -
3
Trends in endpoint selection and result interpretation in advanced non‐small cell lung cancer clinical trials published between 2000 and 2012: A retrospective cohort study by Cristina Fernández‐López, Miguel Ángel Calleja‐Hernández, Jaime Espín Balbino, José Cabeza‐Barrera, José Expósito‐Hernández
Published 2019-04-01
Article -
4
-
5
-
6
2019 SEFH National Survey: service portfolio, care activities, education and research in Spain’s hospital pharmacy departments by Montserrat Pérez-Encinas, Ana Lozano-Blázquez, Javier García-Pellicer, Inmaculada Torre-Lloveras, José Luis Poveda-Andrés, Miguel Ángel Calleja-Hernández
Published 2021-01-01
Article -
7
SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain’s hospital pharmacy departments by Montserrat Pérez-Encinas, Ana Lozano-Blázquez, Javier García-Pellicer, Inmaculada Torre-Lloveras, José Luis Poveda-Andrés, Miguel Ángel Calleja-Hernández
Published 2020-11-01
Article -
8
-
9
Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement by Miguel Ángel Calleja Hernández, Alicia Herrero Ambrosio, María Jesús Lamas Díaz, Julio Martínez Cutillas, Jose Luis Poveda Andrés, Belén Aragón
Published 2017-01-01
Article -
10
Effectiveness and safety of pemetrexed for non-small cell lung cancer in the Andalusian Public Health System by María Antonia Pérez-Moreno, Jesús Cotrina-Luque, Mercedes Galván-Banqueri, Sandra Flores-Moreno, Francisco Javier Bautista-Paloma, Miguel Ángel Calleja-Hernández
Published 2016-11-01
Article -
11
Asociación entre el síndrome coronario agudo y el consumo de antiinflamatorios no esteroideos by José Luis Sánchez Serrano, José María Tenias Burillo, María Isabel Chinchilla Fernández, Laura Jiménez López, Antonio Padilla Serrano, Miguel Ángel Calleja Hernández
Published 2015-01-01
Article -
12
-
13
Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi‐Criteria Decision Analysis by Juan Francisco Silvestre, M. J. Tribó, José C. Armario‐Hita, Miguel Ángel Calleja‐Hernández, Francisco Javier Ortiz‐Frutos, José Luis Poveda, John Shepherd, Esther Serra‐Baldrich
Published 2024-03-01
Article -
14
Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Phar... by Silvia Valero-García, Eva González-Haba, Maria Queralt Gorgas-Torner, José María Alonso-Herreros, Ana Cristina Cercós Lletí, José Luis Poveda-Andrés, Miguel Ángel Calleja-Hernandez, Olga Delgado-Sánchez
Published 2021-03-01
Article -
15
High serum levels of ustekinumab are associated with better clinical outcomes during maintenance treatment for inflammatory bowel disease by Jaime González-Antuña, Teresa Valdés-Delgado, Belén Maldonado-Pérez, María Belvis-Jiménez, Luisa Castro-Laria, Vicente Merino-Bohórquez, Miguel Ángel Calleja-Hernández, Paula Castro-Martínez, Cloe Charpentier, Federico Argüelles-Arias
Published 2024-09-01
Article